Medical Director, Oncology

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . Building on the success of our Phase 3 ROSELLA clinical trial, Corcept’s Oncology Clinical Development team is entering an exciting period of growth. We are seeking a Medical Director, Oncology to play a pivotal role in shaping clinical development strategy and advancing innovative oncology programs from early development through late-stage trials. This is an opportunity to bring your scientific and clinical expertise to a growing pipeline, collaborate with leading investigators and cross-functional teams, and help translate promising science into meaningful new treatment options for patients. Responsibilities: • Act as clinical expert for both internal Company team members and for external contacts related to the assigned therapeutic programs • Provide clinical and scientific leadership including training and ongoing input, to members of the Development and product Core Teams on issues related to the therapeutic field • Provide medical oversight for Company operational staff, CROs and clinical trial sites in areas related to the oncology programs • Design the clinical development plan for indications relevant to assigned molecules programs and support the assessment of the development plans through the cross-functional product core team • Design, develop and implement clinical studies for the applicable drug candidate, from Phase I through Phase III • Establish relationships with external experts in the scientific oncology areas, including principal investigators and opinion leaders, to facilitate scientific excellence in clinical trials research • Establish and approve scientific methods for design and implementation of applicable clinical protocols, data collection systems and final reports • Participate in the writing and review of clinical protocols, investigator brochures, clinical study reports, publications and other documents • Deliver timely and high quality clinical data • Provide medical oversight and safety monitoring for ongoing clinical trials including participation in SAE reporting and serving on the safety committee • Participate in appropriate regulatory discussion and activities, including the filing of IND’s, CTXs, NDA/MAAs, throughout the development cycle • Participate in clinical study report conceptualization, development and writing for global regulatory submissions • Other duties as assigned Preferred Skills, Qualifications and Technical Proficiencies: • Candidates must be excellent communicators with proven leadership skills and the ability to successfully interact in a busy cross functional environment • Ability to establish and maintain a team "sense of urgency" around timelines Preferred Education and Experience: • MD required • Board eligible or certified in an internal medicine subspecialty required; oncology/hematology board certification/eligibility preferred • 2+ years’ clinical development experience in the biotechnology/pharmaceutical industry or an academic clinical trial unit • A proven track record of scholarly clinical research demonstrated by publications in top tier